AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Improvement to Perform Thoracocentesis After a Specific Training in Medical Students With the Supervised Use of an Augmented Reality Simulator

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Strasbourg, France
💬

In plain words

What the trial is, and whether it could suit you

Monocentric study, aiming to assess the improvement of medical students to perform a first-time thoracentesis after training using a specific training using an augmented virtual reality simulator, versus standard training. Study population: medical students from the department of Respirology (University hospital of Strasbourg), performing their first thoracocentesis in patients having an indication for a first-time thoracocentesis. This is not an interventional study, no change in patient course being induced because of the study. After the procedure: use of specific surveys for the patient and for medical students to assess the patient's pain, the patient and the medical student level of anxiety, and the student ability during the procedure.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Medical students : Inclusion criteria: * Medical students between the 4th and 6th year of their medical course, working in the department of respirology at the University hospital of Strasbourg, France, without any prior experience of thoracocentesis. * Older than 18 years old * No opposition to participate to the study (signed consent form). Exclusion criteria: \- Student with a prior experience of pleural procedure (chest tube, thoracocentesis). Patients : Inclusion criteria: * Patients requiring a first-time thoracentesis in routine care. * Older than 18 years old. * Speaking and understanding French. * Valid health insurance. * No opposition to participate to the study (signed consent form). Exclusion criteria: * Patient with previous experience of pleural procedure (thoracocentesis, chest tube…). * Patient having a high-volume pleural effusion according to radiological/ultrasound criteria. * Patient with low-volume pleural effusion according to radiological/ultrasound criteria. * Patient with poor clinical tolerance of the pleural effusion(respiratory instability, dependence on ventilation machine with positive expiratory pressure…). * Patients with higher risk of complication during the procedure (BMI \> 35 kg/m², with increased risk of bleeding…). * Contraindication to the use of Lidocaine. * Local infection. * Impossibility to provide detailed information to the patient. * Subject under legal protection.
💊

What it tests

  • Simulation group
📍

Where

2 sites
Hopitaux Universitaire de Strasbourg
Strasbourg, France
Hôpitaux Universitaires de Strasbourg
Strasbourg, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy